Live Feeds
● LIVE Updated 1h ago · 13 sources tracked

Exclusive | GE HealthCare to Buy Sofie for Nearly $1 Billion to Grow Medical-Imaging Business

GE HealthCare has agreed to purchase radiopharmaceutical company Sofie Biosciences for $945 million, expanding its medical-imaging and fast-growing imaging drug operations. The transaction will provide GE HealthCare with a final mile footprint for positron emission tomography radiopharmaceutical supply across the United States. Trilantic North America is selling Sofie Biosciences to the buyer. Financial institutions and analysts have reacted to the deal, with Needham reiterating its stock rating for GE HealthCare and noting the move vertically integrates the company radiopharma portfolio.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~3 min
Speed:
RSS Source map (13)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ GE HealthCare is acquiring Sofie Biosciences for $945 million.
  • ✓ The purchase is intended to strengthen GE HealthCare medical-imaging and radiopharma business.
  • ✓ Sofie Biosciences brings a U.S. network of 15 Contract Manufacturing Organization sites and a Contract Development and Manufacturing Organization site to the buyer.
  • ✓ Trilantic North America is selling SOFIE Biosciences to GE HealthCare.
🛡️ Source Corroboration: 13 independent reporting domains (100% confidence) ⏱ Read time: ~2 min

What changed

GE HealthCare announced a definitive agreement to acquire Sofie Biosciences for $945 million to expand its radiopharmaceutical and medical-imaging business.

Live updates

  1. GE HealthCare to Buy Sofie Biosciences for $945 Million

    GE HealthCare has agreed to purchase radiopharmaceutical company Sofie Biosciences for $945 million, expanding its medical-imaging and fast-growing imaging drug operations. The transaction will provide GE HealthCare with a final mile footprint for positron emission tomography radiopharmaceutical supply across the United States. Trilantic North America is selling Sofie Biosciences to the buyer. Financial institutions and analysts have reacted to the deal, with Needham reiterating its stock rating for GE HealthCare and noting the move vertically integrates the company radiopharma portfolio.

    Why it matters

    The acquisition strengthens GE HealthCare presence in the expanding radiopharmaceuticals market by adding physical production infrastructure. Sofie Biosciences brings a United States network consisting of 15 Contract Manufacturing Organization sites and a Contract Development and Manufacturing Organization site. Legal counsel for the transaction includes the law firm Sidley representing GE HealthCare.

    What is confirmed

    • GE HealthCare is acquiring Sofie Biosciences for $945 million.
    • The purchase is intended to strengthen GE HealthCare medical-imaging and radiopharma business.
    • Sofie Biosciences brings a U.S. network of 15 Contract Manufacturing Organization sites and a Contract Development and Manufacturing Organization site to the buyer.
    • Trilantic North America is selling SOFIE Biosciences to GE HealthCare.
    • Needham reiterated its GE HealthCare stock rating following the acquisition announcement.

    What to watch next

    • Regulatory approvals and closing conditions for the $945 million acquisition
    • Integration milestones regarding Sofie Biosciences U.S. manufacturing sites
    Sources used for this update (14)
    1. www.dictionary.com — Meanings & Definitions of English Words | Dictionary.com
    2. WSJ — Exclusive | GE HealthCare to Buy Sofie for Nearly $1 Billion to Grow Medical-Imaging Business
    3. GE HealthCare — GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.
    4. Reuters — GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business
    5. pehub.com — Trilantic North America inks $945m sale of SOFIE Biosciences to GE HealthCare
    6. Investing.com India — Needham reiterates GE HealthCare stock rating on Sofie acquisition By Investing.com
    7. Yahoo Finance — GE Healthcare's Sofie Deal to Vertically Integrate Radiopharma Portfolio, Needham Says
    8. The Business Journals — GE HealthCare makes $945M acquisition to bolster its PET business
    9. Crain's Chicago Business — GE HealthCare pays $945M to bolster fast-growing imaging drug business
    10. openPR.com — Radiopharmaceuticals Market Gains Momentum as GE HealthCare Announces US$945 Million SOFIE Acquisition
    11. www.youtube.com — Good Morning America Full Broadcast — Monday, October 5, 2026
    12. www.snapchat.com — Lady Gaga (@ladygaga) | Snapchat Stories, Spotlight & Lenses
    confidence 100%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community